Please ensure Javascript is enabled for purposes of website accessibility

Amwell's Revenue Soars in Q4, but Its Net Loss Soars, Too

By Keith Speights - Mar 25, 2021 at 6:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The telehealth company expects its growth to slow in 2021.

It's been a dismal year for American Well (AMWL -3.74%) so far. Shares of the telehealth-services provider have fallen close to 28%. And that downtrend could continue.

Amwell announced its fourth-quarter results after the market closed on Wednesday. The healthcare stock slipped over 1% in after-hours trading. Here are the highlights from Amwell's Q4 update.

Woman sitting at table looking at a laptop PC showing a smiling doctor

Image source: Getty Images.

By the numbers

Amwell reported fourth-quarter revenue of $60.4 million, a 34% increase from the $45 million reported in the same quarter of the previous year. This result topped the average analyst's revenue estimate of $54 million.

The company delivered a net loss in Q4 of $50.6 million. In the prior-year period, Amwell posted a net loss of $22.7 million. 

Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) also trended in the wrong direction. Amwell recorded an adjusted EBITDA loss in the fourth quarter of $35.4 million, versus an adjusted EBITDA loss of $16.9 million in the prior-year period.

The telehealth provider ended the fourth quarter with cash, cash equivalents, and investments totaling a little over $1 billion. Amwell reported a cash position of $177.6 million as of Dec. 31, 2019.

Behind the numbers

It's easy to discern why Amwell's revenue grew considerably in the fourth quarter. The COVID-19 pandemic continued to drive the company's growth.

Amwell's total active providers increased to around 72,000 in the fourth quarter of 2020 from around 7,000 in the prior-year period and 62,000 in the third quarter. The company reported roughly 1.6 million total visits in Q4, up from 355,000 visits in the same period of 2019.

Around 23% of that total came from Amwell Medical Group (AMG) visits. AMG is a physician-owned medical practice that uses Amwell platforms to provide virtual care.

The company's bottom line suffered as operating expenses increased significantly. Amwell's gross margin also slipped to 37.4% from 44.7% in the prior-year period, due primarily to a shift in the company's revenue mix.

Looking ahead

Amwell projects that revenue for full-year 2021 will be between $260 million and $270 million. The midpoint of this range reflects a year-over-year increase of 8%. Analysts were expecting revenue to fall close to the upper end of the range.

The company also looks for its adjusted EBITDA to deteriorate in 2021. Amwell's outlook calls for negative adjusted EBITDA between $157 million and $147 million.

Investors will definitely want to watch the changing competitive dynamics for Amwell. Internet giant Amazon.com recently announced plans to expand its Amazon Care telehealth services to other employers beginning this summer. It's too early, though, to predict what the impact of Amazon's entry into the market might be for Amwell.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

American Well Corporation Stock Quote
American Well Corporation
AMWL
$3.09 (-3.74%) $0.12
Amazon.com, Inc. Stock Quote
Amazon.com, Inc.
AMZN
$2,216.21 (-1.98%) $-44.89

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
345%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.